- Take a targeted approach to reach the right patients
- Get the full picture of the patient population
- Enable your sites to be more efficient
Rare disease research is accelerating — but many patients still experience long diagnostic delays, limited clinical trial awareness, and barriers to participation.
To help address these persistent challenges, we’ve curated resources that highlight evidence‑based strategies, real-world example, and data‑driven approaches that help sponsors reach low‑prevalence and ultra‑rare populations more effectively.
Explore the resources below to see how Citeline supports rare disease studies with AI, real‑world data, and patient‑centered solutions.
FEATURED CONTENT
Improving Rare Disease Patient RecruitmentDiscover the key challenges shaping rare disease research today — from diagnostic delays to structural barriers — and evidence-based strategies to improve patient identification and trial readiness.
Download the white paper
Explore the case studies
Our Recruitment Solution
PRODUCT INFORMATION
Citeline PatientMatch Product Deep DiveUnderstand how Citeline's AI and real-world data-powered solution identifies protocol matched patients earlier across claims, lab data, EHR insights, and NLP analyzed clinical notes.
Understand our approach
Why Improving Rare Disease Recruitment Matters
Earlier identification
Better use of RWD, lab data, and NLP helps surface eligible patients sooner in their care journey.
Reduced burden for sites
Higher-quality matches minimize manual chart review and reduce screen fail rates.
Expand visibility
AI-powered insights help sponsors understand where rare disease patients receive care and how to reach them more effectively.
Ready to Improve Rare Disease Recruitment?
Explore how Citeline can support your protocol and accelerate patient identification for rare and ultra rare studies.
To enable the booking feature, please enable all cookies in your browser.